Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

6,858 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway Inhibitors.
Yoshida Y, Takahashi M, Komine K, Taniguchi S, Yamada H, Sasaki K, Umegaki S, Kawamura Y, Kasahara Y, Ouchi K, Imai H, Saijo K, Shirota H, Takenaga N, Ishioka C. Yoshida Y, et al. Among authors: sasaki k. Intern Med. 2024 Jun 13. doi: 10.2169/internalmedicine.3373-23. Online ahead of print. Intern Med. 2024. PMID: 38866528 Free article.
Depth of response may predict clinical outcome in patients with recurrent/metastatic head and neck cancer treated with pembrolizumab-containing regimens.
Saijo K, Imai H, Ouchi K, Sasaki K, Yoshida Y, Kawamura Y, Taniguchi S, Kasahara Y, Komine K, Shirota H, Takahashi M, Ishioka C. Saijo K, et al. Among authors: sasaki k. Front Oncol. 2023 Aug 16;13:1230731. doi: 10.3389/fonc.2023.1230731. eCollection 2023. Front Oncol. 2023. PMID: 37664016 Free PMC article.
FOLFIRI Chemotherapy for Patients With Metastatic Urachal Carcinoma.
Taniguchi SH, Komine K, Takenaga N, Yoshida Y, Sasaki K, Kawamura Y, Kasahara Y, Ouchi K, Imai H, Saijo K, Shirota H, Takahashi M, Ishioka C. Taniguchi SH, et al. Among authors: sasaki k. Anticancer Res. 2023 Dec;43(12):5699-5704. doi: 10.21873/anticanres.16775. Anticancer Res. 2023. PMID: 38030182
Genome-wide DNA methylation status is a predictor of the efficacy of anti-EGFR antibodies in the second-line treatment of metastatic colorectal cancer: Translational research of the EPIC trial.
Ouchi K, Takahashi S, Sasaki K, Yoshida Y, Taniguchi S, Kasahara Y, Komine K, Imai H, Saijo K, Shirota H, Takahashi M, Ishioka C. Ouchi K, et al. Among authors: sasaki k. Int J Colorectal Dis. 2024 Jun 11;39(1):89. doi: 10.1007/s00384-024-04659-y. Int J Colorectal Dis. 2024. PMID: 38862615 Free PMC article.
6,858 results